aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Mar 30, 2016 · 10-K · 90 days after period end · 0001564590-16-015652
| Metric | Q4 2015 | Q4 2014 |
|---|---|---|
| Net Income | -$16.49M | -$6.04M |
| EPS Diluted | -$0.70 | -$7.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 30, 2016 · 90 d after period end
